INOZYME PHARMA, INC. Comprehensive Income
INOZYME PHARMA, INC. reported Comprehensive Income of -$28.11 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-05-14
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$28.11M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$27.19M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$24.28M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$27.03M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$102.00M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$70.92M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$67.28M.
- INOZYME PHARMA, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$56.61M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$28.11M 10-Q · filed 2025-05-14 | -$55.30M derived: sum of 2 quarters · filed 2025-05-14 | -$79.58M derived: sum of 3 quarters · filed 2025-05-14 | -$106.62M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | -$27.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$51.47M derived: sum of 2 quarters · filed 2025-03-10 | -$78.50M derived: sum of 3 quarters · filed 2025-03-10 | -$102.00M 10-K · filed 2025-03-10 |
| 2024-09-30 | -$24.28M 10-Q · filed 2024-11-05 | -$51.31M derived: sum of 2 quarters · filed 2024-11-05 | -$74.81M 10-Q · filed 2024-11-05 | -$96.23M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | -$27.03M 10-Q · filed 2024-08-06 | -$50.52M 10-Q · filed 2024-08-06 | -$71.95M derived: sum of 3 quarters · filed 2025-05-14 | -$88.72M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | -$23.49M 10-Q · filed 2025-05-14 | -$44.92M derived: sum of 2 quarters · filed 2025-05-14 | -$61.69M derived: sum of 3 quarters · filed 2025-05-14 | -$77.18M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$21.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$38.19M derived: sum of 2 quarters · filed 2025-03-10 | -$53.69M derived: sum of 3 quarters · filed 2025-03-10 | -$70.92M 10-K · filed 2025-03-10 |
| 2023-09-30 | -$16.77M 10-Q · filed 2024-11-05 | -$32.26M derived: sum of 2 quarters · filed 2024-11-05 | -$49.50M 10-Q · filed 2024-11-05 | -$67.77M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$15.50M 10-Q · filed 2024-08-06 | -$32.73M 10-Q · filed 2024-08-06 | -$51.00M derived: sum of 3 quarters · filed 2024-08-06 | -$67.45M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$17.23M 10-Q · filed 2024-05-07 | -$35.51M derived: sum of 2 quarters · filed 2024-05-07 | -$51.96M derived: sum of 3 quarters · filed 2024-05-07 | -$67.49M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$18.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$34.72M derived: sum of 2 quarters · filed 2024-03-12 | -$50.25M derived: sum of 3 quarters · filed 2024-03-12 | -$67.28M 10-K · filed 2024-03-12 |
| 2022-09-30 | -$16.45M 10-Q · filed 2023-11-07 | -$31.98M derived: sum of 2 quarters · filed 2023-11-07 | -$49.01M 10-Q · filed 2023-11-07 | -$67.75M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$15.53M 10-Q · filed 2023-08-08 | -$32.56M 10-Q · filed 2023-08-08 | -$51.30M derived: sum of 3 quarters · filed 2023-08-08 | -$65.59M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$17.03M 10-Q · filed 2023-05-09 | -$35.77M derived: sum of 2 quarters · filed 2023-05-09 | -$50.06M derived: sum of 3 quarters · filed 2023-05-09 | -$62.60M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$18.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$33.03M derived: sum of 2 quarters · filed 2023-03-22 | -$45.57M derived: sum of 3 quarters · filed 2023-03-22 | -$56.61M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$14.29M 10-Q · filed 2022-11-10 | -$26.83M derived: sum of 2 quarters · filed 2022-11-10 | -$37.87M 10-Q · filed 2022-11-10 | -$48.98M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$12.53M 10-Q · filed 2022-08-15 | -$23.57M 10-Q · filed 2022-08-15 | -$34.69M derived: sum of 3 quarters · filed 2022-08-15 | -$62.80M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$11.04M 10-Q · filed 2022-05-10 | -$22.16M derived: sum of 2 quarters · filed 2022-05-10 | -$50.26M derived: sum of 3 quarters · filed 2022-05-10 | -$59.75M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$11.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$39.22M derived: sum of 2 quarters · filed 2022-03-15 | -$48.71M derived: sum of 3 quarters · filed 2022-03-15 | -$56.43M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$28.11M 10-Q · filed 2021-11-09 | -$37.60M derived: sum of 2 quarters · filed 2021-11-09 | -$45.31M 10-Q · filed 2021-11-09 | -$51.86M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$9.49M 10-Q · filed 2021-08-11 | -$17.20M 10-Q · filed 2021-08-11 | -$23.75M derived: sum of 3 quarters · filed 2021-08-11 | -$27.79M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$7.71M 10-Q · filed 2021-05-12 | -$14.26M derived: sum of 2 quarters · filed 2021-05-12 | -$18.30M derived: sum of 3 quarters · filed 2021-05-12 | -$22.46M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$10.58M derived: sum of 2 quarters · filed 2021-03-25 | -$14.74M derived: sum of 3 quarters · filed 2021-03-25 | -$19.72M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$4.04M 10-Q · filed 2020-11-12 | -$8.20M derived: sum of 2 quarters · filed 2020-11-12 | -$13.17M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$4.16M 10-Q · filed 2020-09-03 | -$9.13M 10-Q · filed 2020-09-03 |